BioBridge Global (BBG) is a U.S.-based nonprofit life sciences organization that supports the development and delivery of cell- and tissue-based therapies. Through subsidiaries including South Texas Blood & Tissue, QualTex Laboratories, GenCure, and BBG Advanced Therapies, the organization provides donor recruitment and management, collection (such as leukapheresis), laboratory testing, processing, storage, and distribution of human-derived starting materials and products.
BBG Advanced Therapies serves as a contract development and manufacturing organization (CDMO) for advanced therapy medicinal products (ATMPs), offering cGMP biomanufacturing and analytical services for cell and gene therapy programs. Operations follow quality systems aligned with FDA, EMA, and PMDA expectations, with capabilities that include assay development, cryopreservation, and controlled logistics. BioBridge Global supports biopharmaceutical developers seeking compliant supply chain, testing, and manufacturing pathways from early development through scale-up.
To provide comprehensive coverage, we aggregate data and news under the name BioBridge, encompassing the following company names, divisions, and related entities:
BBG.
This list encompasses current and former names, alternate names, and key divisions associated with BioBridge, ensuring you can easily find all relevant information under a single, unified profile.